Veracyte’s ASCO 2026 data could sharpen the commercial case for genomic cancer diagnostics
Veracyte’s ASCO data could sharpen the case for genomic testing in breast and prostate cancer. Read why adoption still faces hard tests.
Medical Devices & Diagnostics
Medical Devices & Diagnostics
ClearNote Health targets early pancreatic cancer detection with multi-analyte blood test data
ClearNote Health will present Avantect pancreatic cancer test validation data at ASCO 2026. Find out what it could mean for early detection.
Medical Devices & Diagnostics
Portable MRI in emergency departments: What Hyperfine’s PRIME data changes
Find out how Hyperfine’s PRIME study could reshape emergency brain imaging with faster bedside portable MRI access.
Medical Devices & Diagnostics
Can Inocras’ whole-genome HRD data change how ovarian cancer patients are selected for PARP maintenance?
PARP selection still leaves gaps. Inocras’ WGS-HRD data suggest whole-genome testing may refine ovarian cancer maintenance decisions.
Medical Devices & Diagnostics
Align Technology is betting $200m on Hyderabad. Here’s what changes next
Align needs growth and supply-chain efficiency. Its Hyderabad factory could turn India into a larger digital dentistry manufacturing base.
Medical Devices & Diagnostics
Medtronic’s SPR Therapeutics deal signals a sharper move into earlier chronic pain intervention
Chronic pain care needs non-opioid options. Medtronic’s SPR Therapeutics deal tests whether temporary PNS can scale beyond niche adoption.
Medical Devices & Diagnostics
Why Donor Alliance and LifeSource are building a new model for transplant system performance
Organ donation needs trust and accountability. Vital Impact Health Group tests whether nonprofit OPO collaboration can raise transplant standards.
Medical Devices & Diagnostics
Is Avvio Medical building the next outpatient frontier in kidney stone and ureteral stone therapy?
Ureteral stones need faster care. Avvio Medical’s outpatient device tests whether microbubble lithotripsy can ease OR bottlenecks.
Medical Devices & Diagnostics
Artivion’s Endospan acquisition puts NEXUS at the centre of aortic arch device competition
Artivion now owns NEXUS. The bigger test is whether FDA approval can become a scalable U.S. aortic arch business.
Medical Devices & Diagnostics
HistoSonics just cleared a major Asia hurdle. Could histotripsy move beyond liver tumors next?
HistoSonics cleared Taiwan, but the bigger test is whether histotripsy can scale from liver tumors into broader oncology use.